Madrid, May 26.- Spanish technology company Lleida.net (BME: LLN) (EPA:ALLLN) (OTCQX:LLEIF) increased its active client base by more than 25% in the first quarter of the year. As of March 31, 2025, … [+2512 chars]...
Read moreMadrid, Spain. May 7, 2025 Technology company Lleida.net (BME: LLN) (EPA: ALLN) (OTCQX: LLEIF) received a new research report from Checkpoint Partners, maintaining its 'Buy' rating and setting a pric… [+2631 chars]...
Read moreCitation: Boros PW, Martusewicz-Boros MM, Lewandowska KB (2025) Assessment of lung function and severity grading in interstitial lung diseases (% predicted versus z-scores) and association with survi… [+35120 chars]...
Read moreMadrid, May 5th.- Technology company Lleida.net (BME: LLN) (EPA:ALLN) (OTCQX:LLEIF) recorded its best quarter ever between January and March 2025, with sales of 5.29 million, up 12% on the same perio… [+2945 chars]...
Read moreCitation: Russell ST, Kang M, Kempker JA (2025) An updated comparison of standard and novel FEV1 indices association with all-cause mortality. PLoS One 20(5): e0323681. https://doi.org/10.1371/jou… [+23889 chars]...
Read moreAbstract Background Dolutegravir (DTG)-based antiretroviral therapy has demonstrated superior efficacy, tolerability, and durability when compared to other HIV treatment regimens. However, monitori… [+35120 chars]...
Read more